Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational Approaches to the Rational Design of Tubulin-Targeting Agents
Helena Pérez‐Peña, Anne‐Catherine Abel, M. D. Shevelev, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 285-285
Open Access | Times Cited: 14

Showing 14 citing articles:

Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling
Giancarlo Grossi, Naomi Scarano, Francesca Musumeci, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1739-1739
Open Access | Times Cited: 6
Structure-based discovery and rational design of microtubule-targeting agents
Michel O. Steinmetz, A.E. Prota
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102845-102845
Open Access | Times Cited: 6
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 601-601
Open Access | Times Cited: 4
Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 4
Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents
M Podolak, Serhii Holota, Yaroslava Deyak, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107076-107076
Open Access | Times Cited: 10
Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays
Elena Abbotto, Beatrice Casini, Francesco Piacente, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1316-1316
Open Access | Times Cited: 9
Describing the ligandin properties of Plasmodium falciparum and vivax glutathione transferase towards bromosulfophthalein from empirical and computational modelling viewpoints
Olalekan Onisuru, Ikechukwu Achilonu
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Open Access | Times Cited: 2
Identifying and characterising promising small molecule inhibitors of kinesin spindle protein using ligand-based virtual screening, molecular docking, molecular dynamics and MM‑GBSA calculations
Samia A. Elseginy
Journal of Computer-Aided Molecular Design (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 1
AZD7762 induces CRBN dependent BAG3 degradation through ubiquitin-proteasome pathway
Yanli Liao, Chao Yuan, Mi Huang, et al.
Anti-Cancer Drugs (2023)
Open Access | Times Cited: 2
Interaction of norsecurinine-type monomeric and dimeric alkaloids with α-tubulin: a molecular docking study
Gérard Vergoten, Christian Bailly
(2024), pp. 277-291
Open Access
The influence of the microtubule-targeting agent pretubulysin on inflammatory processes of the vascular endothelium
Tobias Primke
(2024)
Open Access
Investigação de moduladores da tubulina com propriedades anticâncer
Matheus da Silva Souza
(2024)
Open Access
Exploring binding mechanisms of omicron spike protein with dolutegravir and etravirine by molecular dynamics simulation, principal component analysis, and free binding energy calculations
Samia A. Elseginy
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Closed Access | Times Cited: 1
Electrical properties of cancer cells: A next generation biophysical therapeutic target
Akshat Sarkari, Emil Lou
Physics of Life Reviews (2023) Vol. 47, pp. 110-112
Closed Access
Page 1

Scroll to top